‘Eddie and the Cruisers’ With Bill Simmons, Chris Ryan, and Van Lathan

Speaker 00:00

Snoring, gasping during sleep, feeling fatigued? Wake up to Zepbound, tirzepatide, the first and only FDA-approved prescription medicine for moderate to severe obstructive sleep apnea, OSA, in adults with obesity. Zepbound is an injectable prescription medicine that may help adults with moderate to severe obstructive sleep apnea, OSA, and obesity to improve their OSA. Zepbound should be used with a reduced calorie diet and increased physical activity. Zepbound is approved as a 2.5, 5, 7.5, 10, 12.5, or 15 milligram injection. Zepbound contains tirzepatide and should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines. It is not known if Zepbound is safe and effective for use in children. Do not share needles or pens or reuse needles. Don't take Zepbound if allergic to it, or if you or someone in your family had medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2. Tell your doctor if you get a lump or swelling in your neck. Stop Zepbound and call your doctor if you have severe stomach pain or a serious allergic reaction. Severe side effects may include inflamed pancreas or gallbladder problems. Tell your doctor if you experience vision changes, depression, or suicidal thoughts before scheduled procedures with anesthesia, if you're nursing, pregnant, plan to be, or are taking birth control pills. Taking Zepbound with a sulfonylurea or insulin may cause low blood sugar. Side effects include nausea, diarrhea, and vomiting, which can cause dehydration and worsen kidney problems. Talk to your doctor. Call 1-800-545-5979 or visit zepbound.lilly.com. Zepbound and its delivery device, Base and QuickPen, are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.